Abstract
We screened a library of microbial extracts and compounds library using our constructed assay cells and found pulicatins F (1) and G (2), and cyclopiazonic acid (CPA) (3) as Notch activators. Pulicatin F (1) and (±)-pulicatin G were synthesized and their activities were evaluated. Notch activation of CPA (3) was investigated using Western blot and RT-PCR. CPA (3) increased protein level of HES1 and mRNA expression of HES1. Also, the expression of FMS-like tyrosine kinase 3 (FLT3), which was known to inhibit apoptosis, was also inhibited by CPA (3) addition. The Notch activation by CPA (3) and cytotoxicity against HL-60 were clearly canceled by addition of FK506, which is an inhibitor of calcineurin (CaN). In addition, it was revealed that CPA (3) induced apoptosis in HL-60 cells.
Similar content being viewed by others
References
Andersson ER, Sandberg R, Lendahl U. Notch signaling: simplicity in design, versatility in function. Development. 2011;138:3593–612.
Borggrefe T, Oswald F. The notch signaling pathway: transcriptional regulation at Notch target genes. Cell Mol Life Sci. 2009;66:1631–46.
Chitnis A, Bally-Cuif L. The notch meeting: an odyssey from structure to function. Development. 2016;143:547–53.
Kovall RA, Gebelein B, Sprinzak D, Kopan R. The canonical notch signaling pathway: structural and biochemical insights into shape, sugar, and force. Dev Cell. 2017;41:228–41.
Lobry C, Oh P, Mansour MR, Look AT, Aifantis I. Notch signaling: switching an oncogene to a tumor suppressor. Blood. 2014;123:2451–9.
Weng AP, Ferrando AA, Lee W, Morris JP 4th, Silverman LB, Sanchez-Irizarry C, Blacklow SC, Look AT, Aster JC. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science. 2004;306:269–71.
Andersson ER, Lendahl U. Therapeutic modulation of Notch signalling — are we there yet? Nat Rev Drug Discov. 2014;13:357–78.
Gojo I, Karp JE. New strategies in acute myelogenous leukemia: leukemogenesis and personalized medicine. Clin Cancer Res. 2014;20:6233–41.
Sakamoto KM, Grant S, Saleiro D, Crispino J, Hijiya N, Giles F, Platanias L, Eklund EA. Targeting novel signaling pathways for resistant acute myeloid leukemia. Mol Genet Metab. 2015;114:397–402.
Kato T, Sakata-Yanagimoto M, Nishikii H, Ueno M, Miyake Y, Yokoyama Y, Asabe Y, Kamada Y, Muto H, Obara N, Suzukawa K, Hasegawa Y, Kitabayashi I, Uchida K, Hirao A, Yagita H, Kageyama R, Chiba S. Hes1 suppresses acute myeloid leukemia development through FLT3 repression. Leukemia. 2015;29:576–85.
Ye Q, Jiang J, Zhan G, Yan W, Huang L, Hu Y, Su H, Tong Q, Yue M, Li H, Yao G, Zhang Y, Li H. Small molecule activation of NOTCH signaling inhibits acute myeloid leukemia. Sci Rep. 2016;6:26510.
LaFoya B, Munroe JA, Albig AR. A comparison of resveratrol and other polyphenolic compounds on Notch activation and endothelial cell activity. PLoS One. 2019;14:e0210607.
Yoneyama T, Arai MA, Akamine R, Koryudzu K, Sadhu SK, Ahmed F, Itoh M, Okamoto R, Ishibashi M. Notch inhibitors from Calotropis gigantea that induce neuronal differentiation of neural stem cells. J Nat Prod. 2017;80:2453–61.
Arai MA, Akamine R, Tsuchiya A, Yoneyama T, Koyano T, Kowithayakorn T, Ishibashi M. The notch inhibitor cowanin accelerates nicastrin degradation. Sci Rep. 2018;8:5376.
Arai MA, Akamine R, Hayashi N, Koyano T, Kowithayakorn T, Ishibashi M. The notch inhibitors isolated from Nerium indicum. J Nat Prod. 2018;81:1235–40.
Thissera B, Alhadrami HA, Hassan MHA, Hassan HM, Behery FA, Bawazeer M, Yaseen M, Belbahri L, Rateb ME. Induction of cryptic antifungal pulicatin Derivatives from Pantoea Agglomerans by microbial co-culture. Biomolecules. 2020;10:268.
Fu P, Kong F, Wang Y, Wang Y, Liu P, Zuo G, Zhu W. Antibiotic metabolites from the coral-associated actinomycete Streptomyces sp. OUCMDZ-1703. Chin J Chem. 2013;31:100–4.
Lin Z, Antemano RR, Hughen RW, Tianero MD, Peraud O, Haygood MG, Concepcion GP, Olivera BM, Light A, Schmidt EW. Pulicatins A-E, neuroactive thiazoline metabolites from cone snail-associated bacteria. J Nat Prod. 2010;73:1922–6.
Stirewalt DL, Radich JP. The role of FLT3 in haematopoietic malignancies. Nat Rev Cancer. 2003;3:650–65.
Lisovsky M, Estrov Z, Zhang X, Consoli U, Sanchez-Williams G, Snell V, Munker R, Goodacre A, Savchenko V, Andreeff M. Flt3 ligand stimulates proliferation and inhibits apoptosis of acute myeloid leukemia cells: regulation of Bcl-2 and Bax. Blood. 1996;88:3987–97.
Seidler MW, Jona I, Vegh M, Martonosi A. Cyclopiazonic acid is a specific inhibitor of the Ca2+-ATPase of Sarcoplasmic Reticulum. J Biol Chem. 1989;264:17816–23.
Kasahara A, Cipolat S, Chen Y, Dorn GW, Scorrano L. Mitochondrial fusion directs cardiomyocyte differentiation via calcineurin and notch signaling. Science. 2013;342:734–7.
Acknowledgements
We deeply thank to Prof. Kiyotake Suenaga, Keio University and Prof. Arihiro Iwasaki, Chuo University for measurement of Ca2+ concentration in the cells. This study was supported by a Grant-in-Aid for Scientific Research (B) (21H02639 [MAA]) from the Japan Society for the Promotion of Science (JSPS) and a Grant-in-Aid for Transformative Research Area (A) “Latent Chemical Space” (23H04880 [MAA], 23H04884 [MAA]) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Suzuki, S., Saito, S., Narushima, Y. et al. Notch activator cyclopiazonic acid induces apoptosis in HL-60 cells through calcineurin activation. J Antibiot 77, 30–38 (2024). https://doi.org/10.1038/s41429-023-00673-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41429-023-00673-4
- Springer Japan KK